Today: 1 May 2026
Browse Category

NYSE:UNH 15 November 2025 - 9 December 2025

UnitedHealth Group (UNH) Stock Today: Price, West Virginia Opioid Lawsuit, Guidance Raise and 2026 Forecasts

UnitedHealth Group (UNH) Stock Today: Price, West Virginia Opioid Lawsuit, Guidance Raise and 2026 Forecasts

UnitedHealth Group shares traded near $324 Tuesday afternoon, little changed despite a new opioid lawsuit from West Virginia and ongoing DOJ probes. The stock is up about 35% year-to-date, far outpacing the S&P 500. Management raised 2025 earnings guidance last week. Wall Street targets imply nearly 20% upside, though short-term trading models flag weakness.
9 December 2025
··
UnitedHealth Group (UNH) Stock: 2026 Comeback Hopes After a Brutal 2025 – What Investors Need to Know Today (December 8, 2025)

UnitedHealth Group (UNH) Stock: 2026 Comeback Hopes After a Brutal 2025 – What Investors Need to Know Today (December 8, 2025)

UnitedHealth Group shares traded near $325 on December 8, 2025, down about 34% year-to-date after surging medical costs, a major cyberattack, and DOJ investigations. The company raised 2025 EPS guidance to at least $14.90 GAAP and $16.25 adjusted. UNH went ex-dividend today for a $2.21 quarterly payout, yielding 2.7%. Analyst targets imply mid-teens upside from current levels.
8 December 2025
·
UNH Stock Outlook on December 6, 2025: Can UnitedHealth’s Turnaround Power a 2026 Rebound?

UNH Stock Outlook on December 6, 2025: Can UnitedHealth’s Turnaround Power a 2026 Rebound?

UnitedHealth Group shares closed at $330.91 on December 6, down about a third in 2025 and more than 40% below their late-2024 peak. The stock swung sharply this week, driving a 400-point Dow rally on December 3 and a 150-point drop the next day. Hedge fund Epoch Investment Partners cut its stake by 82% in Q2. UnitedHealth’s medical cost ratio surged to nearly 90% in 2025, forcing a major earnings guidance cut.
6 December 2025
·
UnitedHealth Group (UNH) Stock on December 5, 2025: Recovery Rally, 2026 Forecasts and the Legal Risks Investors Can’t Ignore

UnitedHealth Group (UNH) Stock on December 5, 2025: Recovery Rally, 2026 Forecasts and the Legal Risks Investors Can’t Ignore

UnitedHealth shares traded at $332–$334 on December 5, 2025, rebounding from May lows in the $230s after a year marked by a DOJ probe and a major data breach. The stock remains about 45% below its December 2024 high near $610. Analysts estimate 2025 EPS at $16.29, down 41% from the prior year. Simply Wall St values UNH at $847 per share, suggesting a 60% discount to intrinsic value.
5 December 2025
··
UnitedHealth Group (UNH) Stock Today: Latest News, Analyst Forecasts and 2026 Outlook as of December 4, 2025

UnitedHealth Group (UNH) Stock Today: Latest News, Analyst Forecasts and 2026 Outlook as of December 4, 2025

UnitedHealth Group shares traded around $333–340 on December 4, 2025, down over 45% from last year’s high after a year marked by a cyberattack, DOJ investigations, and the killing of a top executive. Stephen Hemsley returned as CEO amid the turmoil. Despite the rebound from lows, the stock remains about 25–30% lower year-to-date, underperforming the S&P 500.
4 December 2025
·
UnitedHealth Group (UNH) Stock Surges as Wall Street Backs 2026 Turnaround – Price, Outlook and Key Risks

UnitedHealth Group (UNH) Stock Surges as Wall Street Backs 2026 Turnaround – Price, Outlook and Key Risks

UnitedHealth closed at $339.71 on December 3, up 4.7% after management raised guidance and analysts upgraded price targets. The stock has rebounded about 45% from its lows but remains 45% below its 52-week high. The board approved a $2.21 quarterly dividend, payable December 16. Wolfe Research lifted its price target to $375, citing margin recovery and earnings growth.
4 December 2025
·
UnitedHealth Group (UNH) Stock Today: Price, Forecast and 2026 Recovery Prospects (December 2, 2025)

UnitedHealth Group (UNH) Stock Today: Price, Forecast and 2026 Recovery Prospects (December 2, 2025)

UnitedHealth traded at $325–326 on December 2, 2025, up slightly from Monday’s close of $323.21 but down nearly 50% from late 2024 highs. The stock remains far below its 52-week peak after regulatory scrutiny, a major cyberattack, and operational missteps. Analysts maintain a “Buy” rating, with a consensus price target near $397. Recent research highlights both deep-value potential and ongoing risks.
2 December 2025
·
UnitedHealth Group (UNH) Stock Outlook Before December 1, 2025: Can Bulls Look Past DOJ Risk and Medicare Pressures?

UnitedHealth Group (UNH) Stock Outlook Before December 1, 2025: Can Bulls Look Past DOJ Risk and Medicare Pressures?

UnitedHealth closed Friday at $329.77, down 47% from its 52-week high and about 34–35% lower year to date. The stock remains roughly 40% above its recent low, with after-hours trading at $329.50. Regulatory probes and lawsuits continue to weigh on sentiment despite a Q3 earnings beat and a 2.7% forward dividend yield. Institutional holders control about 88% of shares, with recent filings showing mixed activity.
30 November 2025
UnitedHealth Group (UNH) Stock Update – November 30, 2025: Fresh Valuation Warnings, New Buyers, and Persistent Regulatory Risk

UnitedHealth Group (UNH) Stock Update – November 30, 2025: Fresh Valuation Warnings, New Buyers, and Persistent Regulatory Risk

UnitedHealth closed at $329.77 on November 28, 2025, with a market cap near $299 billion. Shares remain down 34.6% year-to-date and 44.8% over the past year, despite a 3% gain this week. The stock has underperformed the S&P 500 since Q3 earnings. Institutional buying and new analyst coverage have increased recent trading activity.
30 November 2025
·
UnitedHealth Group (UNH) Stock on 29 November 2025: DOJ Probe, Medicare Advantage Shake‑Up and a 45% Slide

UnitedHealth Group (UNH) Stock on 29 November 2025: DOJ Probe, Medicare Advantage Shake‑Up and a 45% Slide

UnitedHealth Group shares closed at $329.77 on Nov. 28, down about 45% over the past year amid a DOJ investigation into Medicare Advantage billing. Third-quarter revenue rose 12% to $113.2 billion, but earnings from operations fell by half. The company raised its full-year earnings outlook and added former FDA commissioner Scott Gottlieb to its board. Institutional investors hold about 88% of the float.
29 November 2025
·
UnitedHealth Group (UNH) Stock Today, November 26, 2025: Price Action, Medicare Shockwaves and What Investors Are Watching

UnitedHealth Group (UNH) Stock Today, November 26, 2025: Price Action, Medicare Shockwaves and What Investors Are Watching

UnitedHealth Group shares rose 1.3% to about $330.63 on Wednesday, rebounding from Tuesday’s close of $326.28 amid news on Medicare commissions, hospital contract talks, and institutional trades. Despite the gain, the stock remains down 46% over the past year. UNH’s market cap stands near $289 billion, with a 52-week range of $234.60 to $622.83. New filings show mixed institutional interest as regulatory scrutiny intensifies.
26 November 2025
·
UnitedHealth Group (UNH) Stock Today, November 25, 2025: Price Surge, Reddit Buzz and New Red Flags for Investors

UnitedHealth Group (UNH) Stock Today, November 25, 2025: Price Surge, Reddit Buzz and New Red Flags for Investors

UnitedHealth shares rose about 2.7% to $327.70 in afternoon trading on November 25, helping lift the Dow as tech stocks weighed on the S&P 500. The stock remains down roughly 35% year-to-date and nearly 47% below its 52-week high. Trading volume topped 2.8 million shares mid-session. UNH has become a focus for retail investors on Reddit, despite its steep 2025 losses.
25 November 2025
·
UnitedHealth Group (UNH) Stock Today, November 24, 2025: ACA Subsidy Relief After a 50% Crash

UnitedHealth Group (UNH) Stock Today, November 24, 2025: ACA Subsidy Relief After a 50% Crash

UnitedHealth Group shares rose 0.6% to around $322 Monday, rebounding slightly after losing nearly half their value over the past year. The stock remains about 50% below its 52-week high, following earnings shocks and fallout from the Change Healthcare cyberattack. Reports that the White House may extend ACA premium subsidies lifted health insurers broadly. UNH’s market cap stands near $292 billion.
24 November 2025
·
Stock Market Today, Nov. 13, 2025: Dow Slides as Disney Plunges and Tech Stocks Drop After Trump Ends Record Shutdown

US Stock Market Today (Nov. 19, 2025): S&P 500 and Nasdaq Rebound as Wall Street Waits for Nvidia Earnings and Fed Minutes

Nvidia shares rose about 2% by midday Wednesday, leading a rebound in US tech stocks ahead of its earnings report after the bell. The S&P 500 climbed 0.25%, snapping a four-day losing streak, while the Nasdaq gained up to 0.8%. The Dow Jones slipped 0.2%, weighed down by UnitedHealth and Boeing. Investors awaited Nvidia’s results and Federal Reserve minutes later in the day.
19 November 2025
······
UnitedHealth Group Stock Surges Amid Analyst Upgrades: Is Wall Street Turning Bullish on UNH in 2025?

UNH Stock Forecast for 2026: Can UnitedHealth Survive the DOJ Storm and Medicare Cuts? (Updated November 15, 2025)

UnitedHealth Group shares traded near $321.86 on November 15, 2025, after a volatile year marked by a cyberattack, rising costs, and federal probes. The stock rebounded from a May low of $274, helped by Berkshire Hathaway’s stake. Q3 revenue rose 12% to $113.2 billion, but net margin was 2.1%. Management raised full-year guidance.
15 November 2025
··
1 … 6 7 8 9

Stock Market Today

  • Organon Q1 CY2026 Revenue Falls Short of Estimates Amid Declining Sales
    April 30, 2026, 10:38 PM EDT. Organon (NYSE:OGN) posted Q1 CY2026 revenue of $1.46 billion, missing analyst estimates by 0.7% and declining 3.5% year-on-year. The pharmaceutical firm reported adjusted earnings per share (EPS) of $0.71, 16.8% below expectations, and adjusted EBITDA slightly missed forecasts at $415 million. Despite a rising operating margin of 18.2%, revenue growth has been subdued, with annual declines of 1.5% over two years and stagnant sales near five-year levels. Market capitalization stands at $3.5 billion. Analysts anticipate flat revenue over the next 12 months, reflecting ongoing challenges in demand despite product innovation. The results raise concerns on Organon's business quality and long-term growth prospects in the women's health segment post its 2021 spinoff from Merck.

Latest article

Sandisk Stock Falls After Blowout Q3 Earnings as AI Storage Rally Hits a High Bar

Sandisk Stock Falls After Blowout Q3 Earnings as AI Storage Rally Hits a High Bar

1 May 2026
Sandisk shares dropped about 6% in after-hours trading Thursday despite reporting fiscal Q3 revenue of $5.95 billion, up 251% from a year earlier, and net income of $3.62 billion. The company announced a $6 billion buyback and forecast Q4 revenue of up to $8.25 billion. Gross margin rose to 78.4%. Shares had closed at $1,096.51 before slipping to about $1,030.
Apple Stock Slips After Earnings Beat as iPhone Supply Snag Clouds $100 Billion Buyback

Apple Stock Slips After Earnings Beat as iPhone Supply Snag Clouds $100 Billion Buyback

1 May 2026
Apple reported fiscal Q2 revenue of $111.2 billion and earnings of $2.01 per share, beating analyst estimates. The board approved a $100 billion share buyback and raised the dividend. Shares fell about 1% after hours as iPhone sales missed forecasts and chip supply remained tight. Investors are watching for clarity on AI strategy and the upcoming CEO transition to John Ternus.
Nvidia Stock Falls as Google and Amazon AI Chip Push Tests the AI Trade

Nvidia Stock Falls as Google and Amazon AI Chip Push Tests the AI Trade

30 April 2026
Nvidia shares dropped 4.6% to $199.57 Thursday as investors reacted to Alphabet and Amazon expanding sales of their own AI chips. Alphabet reported Google Cloud revenue up 63% and began selling TPU chips directly to customers. AMD and Broadcom shares rose 5.1% and 3.0%, respectively. Amazon said its Trainium chip line secured $225 billion in revenue commitments.
Go toTop